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Key points 27 
Question: This study examines the incidence of neuropsychiatric conditions within ALS 28 
kindreds. 29 
Findings: This population-based, case–control family aggregation study confirms our 30 
previous epidemiologic observations of an association between ALS and schizophrenia in 31 
Irish kindreds. In addition, a significant family history of suicide, autism and alcohol overuse 32 
was reported in ALS kindreds compared to controls.  33 
Meaning: There are significant differences in the incidence of several neuropsychiatric 34 
conditions in ALS kindreds compared to controls which is not accounted for by the C9orf72 35 
expansion.  36 
  37 
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 39 
Abstract 40 
Importance ALS is a progressive neurodegenerative condition primarily involving the motor 41 
system.  There is increasing epidemiological evidence of an association between ALS and a 42 
wider spectrum of neurodegenerative and neuropsychiatric disorders among family 43 
members, including schizophrenia / psychotic illness and suicidal behaviour.  44 
Objective To examine the frequency and range of neuropsychiatric conditions that occur 45 
within individual ALS kindreds.  46 
Design and Setting A population-based, case–control family aggregation study was 47 
designed. All patients included in the Irish ALS Register between January 2012 and January 48 
2014 with definite, probable, or possible ALS by El Escorial criteria were invited to 49 
participate.  50 
Participants All incident patients in the Irish ALS Register between January 2012 and January 51 
2014 with definite, probable, or possible ALS by El Escorial criteria were invited to 52 
participate (n=202). 75 patients were unable or refused to participate and were excluded. 53 
127 incident ALS patients genotyped for the C9orf72 repeat expansion, and 132 age and 54 
gender matched controls were included in the study.  55 
Main Outcome and Measures The prevalence of defined neuropsychiatric disease in first 56 
and second degree relatives of ALS patients and matched controls was determined. 57 
Results Mean age at diagnosis was 64.2, 58% of patients were female. Reported data from 58 
2116 relatives of patients with ALS included 924 first-degree relatives and 1128 second-59 
degree relatives. Data from controls comprised 829 first- and 1310 second- degree relatives.  60 
78 (61%) of ALS kindreds and 51 (39%) of control kindreds reported at least one first or 61 
second degree relatives with a history of schizophrenia, psychosis, suicide, depression, 62 
alcoholism or autism (RR1.5, 95% CI 1.08-2.17, P=0.017, ). Cluster analysis suggested two 63 
subgroups based on the number of family members with a neuropsychiatric condition: 64 
Expected (0-2) and High (≥3). Within the high sub-group, ALS kindreds (71%) presented a 65 
significantly higher than controls ((71% ALS; X=4.29±1.41; p=.001). A strong family history of 66 
schizophrenia (RR 3.4, 95% CI1.27-9.3, P=0.015), suicide (RR 3.3, 95% CI 1.07-10.05, 67 
p=0.037), autism (RR 10.1, 95% CI 1.3-78.8, p=0.027) and alcohol overuse (RR 1.48, 95% CI 68 
1.01-2.17, p=0.04) was reported in ALS kindreds. 17% of probands with a strong family 69 
history of neuropsychiatric conditions (>3 first or second degree relative) carried the 70 
C9orf72 repeat expansion.   71 
Conclusions and relevance Neuropsychiatric symptoms in addition to schizophrenia, 72 
including obsessive compulsive disorder, autism and alcoholism occur more frequently in 73 
ALS kindreds than controls. The presence of the C9orf72 expansion does not fully account 74 
for this, suggesting the presence of additional pleiotropic genes associated with both ALS 75 
and neuropsychiatric disease in the Irish population.   76 
Introduction  77 
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative condition primarily 78 
involving the motor system.  Recent deep phenotyping studies have provided compelling 79 
evidence of phenotypic heterogeneity, suggesting that ALS is a disease spectrum rather than 80 
a single entity. Though originally considered a pure motor system degeneration, the 81 
spectrum has expanded to include extra-motor involvement in sub-cohorts of ALS patients, 82 
including the presence of behavioural variant frontotemporal dementia (bvFTD) in up to 83 
13% at the time of diagnosis1, with known executive dysfunction, behavioural and social 84 
cognitive change in up to 70% of cases. The phenotypic heterogeneity in bvFTD and ALS can 85 
be attributed in part to pathogenic mechanisms associated with the presence of a 86 
hexanucleotide expansion in C9orf72, which accounts for up to 10% ALS and up to 30% of 87 
FTD in European populations. We, and others, have shown that this variant can also be 88 
associated with a range of neurological and neuropsychiatric phenotypes including bvFTD, 89 
psychosis, Huntington disease phenocopies, obsessive-compulsive disorder and bipolar 90 
affective disorder2-5.  91 
 92 
Using a population-based case control cohort study, we previously demonstrated increased 93 
aggregation of schizophrenia / psychotic illness and suicidal behaviour in ALS cohorts6. 94 
While this was associated with the presence of the C9orf72 variant in ALS probands, in some 95 
cases, higher rates of psychosis and suicidal behaviour were also noted in relatives of 96 
probands who did not carry the C9orf72 repeat expansion. It remains unclear as to whether 97 
this overlap with neuropsychiatric conditions is mediated by other pleiotropic genes of 98 
major effect within individual kindreds, or occurs as a consequence of shared polygenic risk 99 
across the entire ALS spectrum. In favour of the latter, we have recently reported 14% 100 
shared polygenic risk between ALS and Schizophrenia using summary statistics from a 101 
combined ALS/Schizophrenia GWAS analysis7. However, we, and others, have also 102 
demonstrated that the genetic architecture of ALS seems to differ from schizophrenia, and 103 
that rare variants and private mutations are likely to account for a higher proportion of ALS, 104 
providing an explanation for the “missing heritability” in ALS 8-10.   An additional explanation 105 
for missing heritability is the likely presence of genetic pleiotropy, in which a pathogenic 106 
gene variant is associated with more than one phenotypic expression within a kindred. In 107 
this instance, the presence of ALS within a kindred would be interpreted as either sporadic 108 
or familial with incomplete penetrance, as the definition of familial disease purely based on 109 
a recurrence of ALS within the pedigree would be excessively narrow.   110 
 111 
The purpose of this study was to explore the possibility of genetic pleiotropy within ALS 112 
kindreds using a case control design. We have expanded our previous familial aggregation 113 
study of ALS kindreds6 by examining a second incident based cohort of patients with ALS to 114 
determine the extent to which other DSM-IV axis I and II disorders might occur in individual 115 
family members of patients with ALS. The objective was (1) to establish whether these traits 116 
are distributed uniformly across all ALS kindreds and (2) whether they segregate within 117 
individual kindreds suggesting the presence of single/oligogenic pleiotropic gene variants. 118 
 119 
Methods 120 
A population-based, case–control family aggregation study was designed. All patients 121 
included in the Irish ALS Register between January 2012 and January 2014 with definite, 122 
probable, or possible ALS by El Escorial criteria were invited to participate. 123 
For each patient, an age-  and gender-matched control was recruited at random from the 124 
records of the patient’s general practitioner, or if this proved impossible, from the records 125 
of a general practitioner in the same area. The presence or absence of neuropsychiatric 126 
disease did not form part of the recruitment criteria. The family history questionnaire was 127 
administered only after proband recruitment. 128 
Written consent for the study was obtained from ALS patients and matched controls. The 129 
study was approved by Beaumont Hospital Research Ethics Committee. 130 
 131 
Data Collection 132 
ALS probands and matched controls were asked to complete a family history questionnaire 133 
in which details of neurological and neuropsychiatric conditions reported by all first and 134 
second degree relatives were ascertained. This was followed by a semi-structured interview 135 
with the proband or another family member, where possible. This semi-structured interview 136 
ensured accuracy of the material recorded on the questionnaire, and addressed missing 137 
data where possible.  An identical methodology was used for patients and controls. Details 138 
included questions about medical conditions in parents, siblings and children (first degree 139 
relatives) and grandparents, uncles, and aunts (second degree relatives), aged over 18 140 
years. All respondents were asked specifically about the occurrence among their immediate 141 
relatives of psychiatric conditions (defined by DSM-IV at the time of this study’s inception) 142 
including major psychotic illness (schizophrenia, bipolar disorder), suicide, autism or autistic 143 
spectrum disorder, obsessive compulsive disorder, addiction and alcohol dependence.  144 
 145 
C9orf72 Genotyping   146 
DNA samples were screened using repeat-primed PCR for the presence of a GGGGCC 147 
hexanucleotide repeat expansion in C9orf72. Representative DNA from positive and 148 
negative controls was also analysed by Southern blot to confirm the sensitivity and 149 
specificity of the analysis.  PCR products were analyzed on an Applied Biosystems 3130xl 150 
genetic analyzer and visualized using GeneMapper software (version 4.0). Patients with the 151 
characteristic appearance of the expanded hexanucleotide repeat on repeat-primed PCR 152 
consisting of a decaying series of 30 or more peaks in duplicate were regarded as having a 153 
pathologic expansion as described previously11.  154 
 155 
Statistical Analysis 156 
Baseline characteristics were tested for difference using the chi-square test for 157 
independence. The relative risk (lambda), used in the majority of previously reported family 158 
aggregation studies, was calculated by comparing the risk of developing a disease in the 159 
relatives of ALS patients, compared to the risk in relatives of controls. K-means clustering 160 
was employed as a non-hierarchical method to quantify the presence of psychiatric 161 
diagnoses. Chi-square compared the distribution of ALS kindred to healthy control within 162 
the k-means clusters. Statistical analysis was carried out using SPSS v24 (SPSS Inc, Chicago, 163 
IL). All statistical testing was performed at the conventional 2-tailed a level of 0.05. 164 
 165 
 166 
Results 167 
127 incident ALS patients, diagnosed between 2012-2014, who agreed to complete the 168 
questionnaire on family history, were included in the study. There were no significant 169 
differences in age of diagnosis, gender, site of onset, or the proportion reporting a positive 170 
family history of ALS between this cohort and our previously cohort of 172 ALS patients6. In 171 
addition, there were no significant differences in gender, El Escorial criteria at first 172 
assessment, site of onset, or the proportion reporting a positive family history between 173 
those who agreed to inclusion in the study and were able to provide a comprehensive family 174 
history compared to those who either declined inclusion or were unable to complete a 175 
family history (Table 1).  As in a previous study6 patients who declined to participate, or who 176 
were included in the study were significantly older at symptom onset and diagnosis.  177 
 178 
Reported data from 2116 relatives of patients with ALS included 924 first-degree relatives 179 
and 1128 second-degree relatives. Data from controls comprised 829 first- and 1310 180 
second- degree relatives.  There was no statistical difference between the kindreds of ALS 181 
probands and controls with respect to the number of first and second degree relatives. 182 
Our previously observed increased risk of neuropsychiatric disorders including schizophrenia 183 
/ psychotic illness, and suicide observed in first and second degree relatives of patients with 184 
ALS compared to relatives of controls was replicated (Table 2). Specifically, the relative risk 185 
of developing schizophrenia or other psychotic illness among first and second degree 186 
relatives of ALS probands compared with control was 3.4, p= 0.015, while the relative risk of 187 
death by suicide in first- or second-degree relatives of ALS probands was 3.3, p=0.037.  188 
 189 
The reported frequency of OCD, personality disorders, addiction and alcoholism and autistic 190 
spectrum disorders) was also assessed in patients and controls. DSM criteria for each of 191 
these conditions was applied by the interviewer, and only those cases reporting to fulfil the 192 
criteria, or in whom a confirmed psychiatric diagnosis could be verified were included. 193 
Higher rates of autism, alcohol dependence and other conditions associated with 194 
personality rigidity (obsessive compulsive disorder, and personality disorder) were reported 195 
in the kindreds of ALS probands compared with controls (Table 2). 196 
 197 
 198 
Clustering of neuropsychiatric disease in ALS within kindreds. 199 
Of the 127 ALS probands, 77 (61%) had at least one sibling, parent, uncle, aunt or adult child 200 
with a history of schizophrenia / psychosis / suicide / depression / alcoholism / autism / 201 
other neuropsychiatric condition, compared with 51 (39%) of controls. K-means clustering 202 
identified two distinct subgroups within the data. These subgroups have been defined as an 203 
expected rate: 0-2 affected family members (45% ALS; X= 0.58±0.711; Min= 0; Max =2) and a 204 
high rate of psychiatric illness: ≥3 affected family members (71% ALS; X=4.29±1.41; Min=3; 205 
Max=7). Within the high rate of psychiatric illness group, ALS kindreds represented a 206 
significantly higher rate when compared to health control kindreds (p=.001). This significant 207 
clustering of neuropsychiatric disease within the kindreds of ALS probands was independent 208 
of kindred size, and there was no significant difference between ALS probands and controls 209 
in this regard. ALS probands with higher reported rates of neuropsychiatric disease reported 210 
a mean number of 16 (range 6-32) first and second degree relatives, whereas controls 211 
reported a mean of 21 (range 15-27) first and second degree relatives. 212 
 213 
Neuropsychiatric disease and C9orf72 status  214 
C9orf72 genotyping was available in 111 of the 127 ALS patients (87%). Of these, 19% (21) of 215 
probands carried the repeat expansion, while 81% (90) had a normal C9orf72 repeat 216 
expansion profile.  A history of dementia affecting at least one other family member was 217 
reported in 100% of kindreds of probands carrying the C9orf72 expansion.  This contrasted 218 
with kindreds of ALS probands who were negative for the repeat expansion, in whom 27.5% 219 
(33) reported a diagnosis of dementia in FDRs and SDRs and in controls, where 10% 220 
reported the presence of dementia in FDRs and SDRs.  221 
 222 
The majority of C9orf72 positive ALS kindreds (19 of 21, 90%) also reported at least one 223 
family member with a history of neuropsychiatric disease. The commonest neuropsychiatric 224 
conditions associated with C9orf72 included depression and alcoholism.  However, of the 29 225 
kindreds reporting more than 3 first or second degree relatives with a neuropsychiatric 226 
condition, only 17% (6) of the ALS probands carried the expanded genotype. The remaining 227 
23 (83%) of ALS probands did not carry any of the known pathogenic gene variants.  228 
 229 
Discussion 230 
This study confirms our previous epidemiologic observations of an association between ALS 231 
and schizophrenia in Irish kindreds, and extends the finding to other neuropsychiatric 232 
conditions characterized by impulse dyscontrol, addiction, alcoholism and rigid / autism 233 
spectrum disorder, as defined by DSM-IV.  Our data support the hypothesis that family 234 
members of ALS probands are more likely to exhibit a neuropsychiatric endophenotype that 235 
recapitulates in part the extra motor changes reported in ALS.    236 
  237 
We have shown than 58% of ALS probands reported at least one relative with a history of 238 
schizophrenia, psychosis, suicide, depression, alcohol dependence or autism, compared with 239 
39% of control kindreds (p=0.002).  While neuropsychiatric conditions are common within 240 
the general population as demonstrated by their presence within our control cohort, our 241 
data clearly suggest that kindreds of ALS probands are enriched for these disorders. Of the 242 
participants who clustered in the high rate of familial psychiatric illness (≥3 family members 243 
with psychiatric illness), over 70% were ALS patients (p=.001), with the same mean number 244 
of relatives. Major psychiatric disorders that were specifically over-represented within these 245 
ALS kindreds included schizophrenia / psychosis (p=0.015), suicide (p=0.037), autism 246 
(p=0.027), rigid personality disorders (p=0.02) and alcohol overuse (p=0.045).  247 
 248 
In patients with progressive neruodegenerative disease, the impact of psychological 249 
stressors on the caregivers and wider family network is well recognised. A higher than 250 
expected rate of neuropsychiatric disease in ALS kindreds may well be anticipated as simply 251 
a function of disease-induced stress on the family. However, this study was specifically 252 
designed to address this point as we identified those with neuropsychiatric symptoms that 253 
had been present prior to any knowledge of ALS within kindreds, in which case the diagnosis 254 
would be expected to have no impact on neuropsychiatric presentations within extended 255 
kindreds. Moreover, the absence of evidence of increased rates of depression, which would 256 
be anticipated were the presence of ALS a factor, suggests that the findings are not related 257 
to the presence of ALS  within kindreds.  258 
 259 
Our findings suggest the presence of the C9orf72 repeat expansions does not fully account 260 
for the observed overlap between ALS and neuropsychiatric conditions. While 17% of 261 
probands from kindreds reporting high rates of neuropsychiatric conditions (>3 affected 262 
relatives) carried the C9orf72 repeat expansion, the remaining 83% of probands carried the 263 
normal variant.  264 
 265 
Consistent with our previous study, there was no reported difference in the presence of risk 266 
of underlying depression in the kindreds of the ALS probands compared with controls.  267 
Given that depression is common within the general population and might be expected to 268 
be over-represented in ALS kindreds due to a bias in reporting, this finding supports the 269 
robustness of our finding of a relationship between specific neuropsychiatric conditions and 270 
ALS.  271 
  272 
Indeed, the absence of an association between depression and ALS, despite the presence of 273 
higher rates of reported suicide among first and second degree relatives of ALS probands 274 
may reflect an underlying dysregulation of impulse control, rather than a specific alteration 275 
in mood. While further prospective family studies are required to confirm, the 276 
dichotomization of depression and suicide was also noted in our previous study6.  This 277 
observation is congruent with the emerging concept of network disruption in ALS leading to 278 
a range of behavioural changes including increasing disinhibition, impulse dyscontrol, and in 279 
some cases increased personality rigidity13-16.  280 
 281 
This study was unable to demonstrate a significant association between behavioural change 282 
in ALS probands and the presence of a psychiatric endophenotype among first and second 283 
degree relatives. This was most likely due to the low power of our study, and the relative 284 
insensitivity of the employed behavioural screening tools.  285 
 286 
Our study is limited by design.  The neuropsychiatric signal among first and second degree 287 
relatives was obtained by report rather than by direct examination of family members, and 288 
verification was limited to a series of confirmatory questions by the interviewer. Verification 289 
questions included clarification that the diagnosis had been made by a suitably qualified 290 
medical practitioner.   It is therefore possible that some of the diagnostic categorization is 291 
incomplete. However, this limitation applied to ALS kindreds from probands with and 292 
without the C9orf72 repeat expansion and controls equally, and is therefore unlikely to have 293 
substantially biased our findings. Secondly, it is possible that ALS probands over-reported 294 
the presence of psychiatric disorders. We consider this to be unlikely, as a possible 295 
association between ALS and neuropsychiatric conditions is not commonly known to the 296 
majority of ALS probands.  Moreover, the absence of a significant increase in depression 297 
among family members supports the veracity of our findings.  Our study cohort was slightly 298 
enriched by kindreds of probands carrying the C9orf72 repeat expansion – this is likely an 299 
artifact of our collection method, as some families carrying the C9orf72 expansion have 300 
knowledge of ALS, and more likely to agree to participate in this type of study.   301 
Notwithstanding, our study confirms our previous observation of higher rates of 302 
neuropsychiatric conditions within ALS kindreds.  We have shown that this aggregation is 303 
driven primarily by kindreds enriched for particular neuropsychiatric conditions that 304 
recapitulate the cognitive and behavioural subphenotypes described in ALS, and that this 305 
effect is not primarily driven by the presence of the C9orf72 expansion. Detailed 306 
suphenotyping and genotyping of members of informative kindreds from ALS probands will 307 
be required to further characterize this association which, if replicated, suggests the 308 
presence of a distinct subphenotype of ALS that shares pleiotropic genetic risk with some 309 
forms of neuropsychiatric illness.  310 
K-means clustering was chosen as the process is a two-phase iterative heuristic, with data 311 
assignment, and centroid updating staggered successively17,18. K-means is a partitional 312 
technique used to find clusters, whereby the clusters are represented by their centroids, 313 
e.g., the arithmetic means of data points within the respective clusters. The statistical 314 
convergence of these iterations, which are integral for clusters to be identified, further 315 
increased the integrity and robustness of these analyses alongside the close matched case 316 
and control cohorts.  317 
 318 
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 386 
 387 
 388 
Characteristic Not Included in Study 
(n=75) 
Included in Study 
(n=127) 
P value 
Mean age onset, yr 
(SD) 
67.2 (10.1) 62.8 (10.2) 0.004 
Mean age diagnosis, 
yr (SD) 
68.1 (10.1) 64.2 (10.7) 0.033 
Sex, No. female (%) 30 (40%) 58 (45.6%) 0.47 
Site onset, No. (%) Bulbar, 30 (40); Limb 
38 (50.7); other 7, 
(9.3) 
Bulbar, 35 (27.5); 
Limb, 81 (63.7); other, 
11 (9) 
0.15 
C9orf72 repeat 
status  
 
Positive, 6 (8%); 
Negative, 35 (46.7%); 
Not available, 34 
(45.3%). 
Positive, 21 (16.5%); 
Negative, 90 (70.9%); 
Not available, 16 
(12.6%). 
0.64 
 389 
Table 1. Comparison of the Demographic details of ALS patients included in the study and 390 
those not included.   391 
 392 
 393 
 394 
Disease Relatives of 
Cases, n=2116 
Relatives of 
Controls, n= 2139 
Risk Ratio P 
Suicide 13 4 3.3 0.037 
Schizophrenia / 
psychotic illness 
17 5 3.4 0.015 
Autism 10 1 10.1 0.027 
Depression 35 31 1.14 0.59 
Alcoholism 63 43 1.48 0.045 
OCD and Rigid 
Personality Disorders   
11 2 5.6 0.02 
 395 
Table 2. Prevalence and relative risk of neuropsychiatric conditions in first and second 396 
degree relatives of ALS patients compared to controls relatives. ‘ 397 
  398 
 399 
Number of affected 
individuals per kindred 
ALS Kindreds 
(n=127) 
Control Kindreds 
(n=132) 
0 50 81 
1 32 31 
2 16 14 
3 or more 29 6 
Table 3. Clustering of neuropsychiatric conditions in kindreds of patients with ALS compared 400 
to those of controls. 401 
 402 
 403 
 404 
  405 
 406 
